Advisor Group’s Biogen BIIB Stock Holding History

Advisor Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Buy	+1	New	+$277	﹤0.01%	5100

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Group's BIIB Position: Q4 2019 in Review

Advisor Group increased its Biogen (BIIB) stake by 85% in Q4 2019, buying an estimated $1.87M and bringing the position to 14,678 shares worth $4.36M. The position accounts for 0.03% of the portfolio, ranked #457.

Advisor Group first reported a position in BIIB in Q2 2016 and has held it in 15 quarters since. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

Advisor Group held 14,678 shares of Biogen worth $4.36M as of Q4 2019.
Advisor Group bought 6,741 Biogen shares in Q4 2019, an estimated $1.87M.
Biogen made up 0.03% of Advisor Group's portfolio in Q4 2019, its #457 holding.
Advisor Group first reported a position in Biogen in Q2 2016 and has held it in 15 quarters since.
1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.